BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 32138190)

  • 1. Melatonin's Antineoplastic Potential Against Glioblastoma.
    Moretti E; Favero G; Rodella LF; Rezzani R
    Cells; 2020 Mar; 9(3):. PubMed ID: 32138190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic role of melatonin in migraine prophylaxis: A systematic review.
    Long R; Zhu Y; Zhou S
    Medicine (Baltimore); 2019 Jan; 98(3):e14099. PubMed ID: 30653130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma.
    Fernandez-Gil BI; Otamendi-Lopez A; Bechtle A; Vazquez-Ramos CA; Qosja N; Suarez-Meade P; Sarabia-Estrada R; Jentoft ME; Guerrero-Cázares H; Escames G; Schiapparelli P; Quiñones-Hinojosa A
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The validity of melatonin as an oncostatic agent.
    Panzer A; Viljoen M
    J Pineal Res; 1997 May; 22(4):184-202. PubMed ID: 9247204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin's protective effect against UV radiation: a systematic review of clinical and experimental studies.
    Scheuer C; Pommergaard HC; Rosenberg J; Gögenur I
    Photodermatol Photoimmunol Photomed; 2014 Aug; 30(4):180-8. PubMed ID: 24164339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential utility of melatonin in the treatment of childhood cancer.
    Chao YH; Wu KH; Yeh CM; Su SC; Reiter RJ; Yang SF
    J Cell Physiol; 2019 Nov; 234(11):19158-19166. PubMed ID: 30945299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.
    Reiter RJ; Rosales-Corral SA; Tan DX; Acuna-Castroviejo D; Qin L; Yang SF; Xu K
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin and cisplatin co-treatment against cancer: A mechanistic review of their synergistic effects and melatonin's protective actions.
    Rafiyan M; Davoodvandi A; Reiter RJ; Mansournia MA; Rasooli Manesh SM; Arabshahi V; Asemi Z
    Pathol Res Pract; 2024 Jan; 253():155031. PubMed ID: 38103362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic mechanisms involved in the anti-cancer effects of melatonin.
    Mediavilla MD; Sanchez-Barcelo EJ; Tan DX; Manchester L; Reiter RJ
    Curr Med Chem; 2010; 17(36):4462-81. PubMed ID: 21062257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review on Melatonin's Effects in Cancer: Potential Mechanisms.
    Hanikoglu A; Kucuksayan E; Akduman RC; Ozben T
    Anticancer Agents Med Chem; 2018; 18(7):985-992. PubMed ID: 29173185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin for primary insomnia?
    Drug Ther Bull; 2009 Jul; 47(7):74-7. PubMed ID: 19567841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat.
    Cini G; Coronnello M; Mini E; Neri B
    Cancer Lett; 1998 Mar; 125(1-2):51-9. PubMed ID: 9566696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy.
    Blask DE; Sauer LA; Dauchy RT
    Curr Top Med Chem; 2002 Feb; 2(2):113-32. PubMed ID: 11899096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives.
    Mauriz JL; Collado PS; Veneroso C; Reiter RJ; González-Gallego J
    J Pineal Res; 2013 Jan; 54(1):1-14. PubMed ID: 22725668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin plus exercise-based neurorehabilitative therapy for spinal cord injury.
    Hong Y; Palaksha KJ; Park K; Park S; Kim HD; Reiter RJ; Chang KT
    J Pineal Res; 2010 Oct; 49(3):201-9. PubMed ID: 20626592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic actions of melatonin in cancer: possible mechanisms.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the use of melatonin overcome drug resistance in cancer chemotherapy?
    Asghari MH; Ghobadi E; Moloudizargari M; Fallah M; Abdollahi M
    Life Sci; 2018 Mar; 196():143-155. PubMed ID: 29374563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin for insomnia in children.
    Med Lett Drugs Ther; 2020 Jun; 62(1601):103-104. PubMed ID: 32724024
    [No Abstract]   [Full Text] [Related]  

  • 19. Melatonin as a potential inhibitor of kidney cancer: A survey of the molecular processes.
    Maleki Dana P; Reiter RJ; Hallajzadeh J; Asemi Z; Mansournia MA; Yousefi B
    IUBMB Life; 2020 Nov; 72(11):2355-2365. PubMed ID: 32918860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin and its anti-glioma functions: a comprehensive review.
    Maitra S; Bhattacharya D; Das S; Bhattacharya S
    Rev Neurosci; 2019 Jul; 30(5):527-541. PubMed ID: 30645197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.